State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT05913908 N/A
Recruiting
EFS of the DUO System for Tricuspid Regurgitation
Condition
Tricuspid Regurgitation
Enrollment
15 pts
Location
United States, Poland
Sponsor
CroiValve Limited
NCT03507257 N/A
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Condition
Early Onset Alzheimer Disease
Enrollment
850 pts
Location
United States, Argentina, Netherlands
Sponsor
Indiana University
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT05128006 N/A
Recruiting
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
Condition
New Patient Use of Teledermatology Mobile App
Enrollment
63,200 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06218355 N/A
Recruiting
IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
Condition
Postpartum Complication
Enrollment
3,500 pts
Location
United States
Sponsor
University of Texas Southweste
NCT06118515 Phase 1
Recruiting
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cy...
Condition
Congenital Cytomegalovirus Infection
Enrollment
12 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT07479433 N/A
Recruiting
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of S...
Condition
Coronary Artery Disease (CAD)
Enrollment
5,000 pts
Location
United States
Sponsor
HeartFlow, Inc.
NCT06345690 N/A
Recruiting
VIA Disc NP Registry 3.0
Condition
Discogenic Pain
Enrollment
500 pts
Location
United States
Sponsor
VIVEX Biologics, Inc.
NCT06121297 Phase 1, Phase 2
Recruiting
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of C...
Condition
Systemic Lupus Erythematosus
Enrollment
28 pts
Location
United States, Canada, Spain
Sponsor
Cabaletta Bio
NCT05897320 Phase 3
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Condition
Episodic Migraine
Enrollment
315 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT05079282 Phase 1
Recruiting
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
Condition
Relapsed or Refractory T Cell Lymphoma
Enrollment
217 pts
Location
United States
Sponsor
Ono Pharmaceutical Co. Ltd
NCT07096843 Phase 2
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Condition
Primary Membranous Nephropathy
Enrollment
45 pts
Location
United States, Argentina, Brazil
Sponsor
Climb Bio, Inc.
NCT07441655 N/A
Recruiting
Families Implementing Good Health Traditions for Life
Condition
Diabetes
Enrollment
70 pts
Location
United States
Sponsor
Morehouse School of Medicine
NCT05616546 Phase 4
Recruiting
Bone Marrow and Peripheral Blood Immune Responses Study
Condition
Influenza
Enrollment
90 pts
Location
United States
Sponsor
Emory University
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT05889286 N/A
Recruiting
F18-MHF: Orthopedic Implants-Associated Infection Detection
Condition
Knee Disease
Enrollment
30 pts
Location
United States
Sponsor
Emory University
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05412927 N/A
Recruiting
AngelMed Guardian® System PMA Post Approval Study
Condition
Acute Coronary Syndrome
Enrollment
500 pts
Location
United States
Sponsor
Angel Medical Systems
NCT06827990 N/A
Recruiting
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissection...
Condition
Aortic Dissection
Enrollment
112 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05143840 Phase 2
Recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chron...
Condition
Chronic Myeloid Leukemia, Chronic Phase
Enrollment
100 pts
Location
United States
Sponsor
Augusta University